|Project Title||Anti-Tumor Necrosis Factor (TNF) Utilization Among Pregnant Women|
Wednesday, December 20, 2017
This report contains estimates of use of five tumor necrosis factor (TNF)-alpha inhibitors, etanercept, adalimumab, infliximab, certolizumab, and golimumab, that occurred during a pregnancy resulting in a liveborn delivery, or within 90 days prior to the estimated start of pregnancy. The query was run against the Sentinel Distributed Database (SDD) for the time period of January 1, 2004 to September 30, 2015. This request was distributed to 16 Data Partners on June 27, 2017.
tumor necrosis factor (TNF) alpha inhibitor
|Population / Cohort|
Females 15-54 years of age
January 1, 2004 - September 30, 2015
Sentinel Distributed Database (SDD)